Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.2 DKK | 0.00% | -5.19% | +6.38% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 869M 6.06B | Sales 2025 * | 945M 6.59B | Capitalization | 1.79B 12.45B |
---|---|---|---|---|---|
Net income 2024 * | 72M 502M | Net income 2025 * | 86M 600M | EV / Sales 2024 * | 2.53 x |
Net Debt 2024 * | 412M 2.87B | Net Debt 2025 * | 383M 2.67B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
23.7
x | P/E ratio 2025 * |
19.9
x | Employees | 4,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.4% |
Latest transcript on Embla Medical hf.
1 week | -5.19% | ||
Current month | -12.84% | ||
1 month | -12.97% | ||
3 months | +0.17% | ||
6 months | +11.45% | ||
Current year | +6.38% |
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 29.2 | 0.00% | 27,150 |
24-04-25 | 29.2 | -5.19% | 13,134 |
24-04-24 | 30.8 | +0.33% | 76,638 |
24-04-23 | 30.7 | +1.99% | 68,158 |
24-04-22 | 30.1 | -2.27% | 3,436 |
Delayed Quote Nasdaq Copenhagen, April 26, 2024 at 10:54 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.38% | 1.79B | |
+1.84% | 24.07B | |
+7.40% | 13.7B | |
+10.34% | 10.18B | |
-17.75% | 2.06B | |
+41.47% | 1.73B | |
+13.26% | 589M | |
0.00% | 400M | |
+27.40% | 135M | |
+21.80% | 93.49M |
- Stock Market
- Equities
- EMBLA Stock